In today’s era of sensitivity to health and healthcare cost issues, one frequent topic of discussion is end stage renal disease. In the U.S., the Center for Disease Control and Prevention found that chronic kidney disease affected almost 17% of the adult population during 1999 to 2004 and that number is growing. The purpose of this paper is to describe the definition, causes, treatment and financial implications of this disease.
Download full article as featured in the March 2013 edition of The Self-Insurer.
Customer satisfaction equals business success No surprise, there’s a strong positive correlation between customer satisfaction and the financial performance of individual companies. This has been […]
In an article published last week in the leading cancer journal, Annals of Oncology, researchers reported the following encouraging results of an independent validation study […]